What is the share price of Sai Life Sciences Limited (SAILIFE) today?
The share price of SAILIFE as on 2nd November 2026 is ₹1542.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Sai Life Sciences Limited (SAILIFE) share?
The past returns of Sai Life Sciences Limited (SAILIFE) share are- Past 1 week: 11.43%
- Past 1 month: 0.03%
- Past 3 months: 17.66%
- Past 6 months: 43.04%
- Past 1 year: 67.69%
- Past 3 years: N/A%
- Past 5 years: 102.35%
What are the peers or stocks similar to Sai Life Sciences Limited (SAILIFE)?
The peers or stocks similar to Sai Life Sciences Limited (SAILIFE) include:What is the market cap of Sai Life Sciences Limited (SAILIFE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sai Life Sciences Limited (SAILIFE) is ₹33092.63 Cr as of 2nd November 2026.What is the 52 week high and low of Sai Life Sciences Limited (SAILIFE) share?
The 52-week high of Sai Life Sciences Limited (SAILIFE) is ₹1697 and the 52-week low is ₹783.85.What is the PE and PB ratio of Sai Life Sciences Limited (SAILIFE) stock?
The P/E (price-to-earnings) ratio of Sai Life Sciences Limited (SAILIFE) is 94.85. The P/B (price-to-book) ratio is 13.32.Which sector does Sai Life Sciences Limited (SAILIFE) belong to?
Sai Life Sciences Limited (SAILIFE) belongs to the Health Care sector & Biotechnology sub-sector.How to buy Sai Life Sciences Limited (SAILIFE) shares?
You can directly buy Sai Life Sciences Limited (SAILIFE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Sai Life Sciences Limited
SAILIFE Share Price
NSESAILIFE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SAILIFE Performance & Key Metrics
SAILIFE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 91.49 | 13.32 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.81 | 5.76 | 0.50% |
from 8 analysts
Price Upside
Earnings Growth
Rev. Growth
SAILIFE Company Profile
Sai Life Sciences Limited is a contract research, development, and manufacturing organization (CRO/CDMO) providing tailored services for pharmaceutical and biotechnology industries, from drug discovery to commercial launch.
SAILIFE Sentiment Analysis
SAILIFE Sentiment Analysis
SAILIFE Stock Summary · May 2026
Management framed the quarter as a validation of its integrated CRDMO strategy, reporting revenue growth of 29% year‑on‑year and announcing a stepped‑up FY27 capex program of INR 1,100–1,300 crore to support the next phase of expansion. They highlighted broad‑based growth across CRO and CDMO, deeper multi‑service engagements with large pharma clients and a growing late‑stage pipeline, while stressing priorities on capacity buildouts, automation, DMPK/biology scale, ADC and peptide capability development and targeted AI/digital investments to lift productivity. Management struck a confident but measured tone, noting stronger CDMO visibility and several recently commercialized products expected to contribute in FY27, yet acknowledging tensions: customer concentration and supply‑chain cost pressures, short‑term inefficiencies and margin volatility as new plants commission, and limited visibility on exact commercialization timing. Looking ahead, they said capex will be phased to customer demand, leverage will remain healthy, CDMO growth is expected to continue and they anticipate FY27 second‑half strength as new capacity and investments come online.
SAILIFE Stock Growth Drivers
SAILIFE Stock Growth Drivers
7Robust FY26 financial performance and improved profitability
The company delivered materially stronger FY26 results with revenue up 29%, EBITDA up 56% and
Integrated CRDMO platform and deepening large‑pharma relationships
The company’s integrated discovery‑to‑commercial CRDMO model is a structural differentiator that is increasing its relevance
SAILIFE Stock Challenges
SAILIFE Stock Challenges
5Geopolitical-driven input and logistics cost pressure
Ongoing geopolitical tensions, including developments in the Middle East, have increased input costs and disrupted
Capex-driven near-term financial strain and efficiency drag
A sizable expansion program is elevating costs and creating funding and efficiency risks: the firm
SAILIFE Forecast
SAILIFE Forecasts
Price
Revenue
Earnings
SAILIFE Share Price Forecast
SAILIFE Share Price Forecast
All values in ₹
All values in ₹
SAILIFE Company Revenue Forecast
SAILIFE Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
SAILIFE Stock EPS (Earnings Per Share) Forecast
SAILIFE Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
SAILIFE
SAILIFE
Income
Balance Sheet
Cash Flow
SAILIFE Income Statement
SAILIFE Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 442.55 | 287.84 | 405.52 | 448.89 | 589.11 | 506.32 | 552.80 | 564.84 | 617.95 | 557.83 | ||||||||||
| Operating & Other expenses | 314.55 | 253.61 | 293.34 | 320.03 | 421.93 | 375.49 | 391.65 | 376.90 | 425.59 | 406.28 | ||||||||||
| EBITDA | 128.00 | 34.23 | 112.18 | 128.86 | 167.18 | 130.83 | 161.15 | 187.94 | 192.36 | 151.55 | ||||||||||
| Depreciation/Amortization | 31.05 | 31.07 | 35.92 | 34.09 | 37.49 | 37.72 | 39.75 | 44.08 | 45.31 | 45.94 | ||||||||||
| PBIT | 96.95 | 3.16 | 76.26 | 94.77 | 129.69 | 93.11 | 121.40 | 143.86 | 147.05 | 105.61 | ||||||||||
| Interest & Other Items | 20.89 | 21.22 | 20.93 | 23.13 | 10.89 | 12.36 | 9.35 | 9.70 | 7.83 | 7.64 | ||||||||||
| PBT | 76.06 | -18.06 | 55.33 | 71.64 | 118.80 | 80.75 | 112.05 | 134.16 | 139.22 | 97.97 | ||||||||||
| Taxes & Other Items | 19.92 | -4.57 | 13.82 | 17.80 | 30.53 | 20.30 | 28.20 | 33.80 | 34.99 | 24.69 | ||||||||||
| Net Income | 56.14 | -13.49 | 41.51 | 53.84 | 88.27 | 60.45 | 83.85 | 100.36 | 104.23 | 73.28 | ||||||||||
| EPS | 31.00 | -0.74 | 2.22 | 2.89 | 4.24 | 2.90 | 4.01 | 4.77 | 4.93 | 3.46 |
SAILIFE Company Updates
Investor Presentation
SAILIFE Stock Peers
SAILIFE Past Performance & Peer Comparison
SAILIFE Past Performance & Peer Comparison
Health CareBiotechnology
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sai Life Sciences Limited | 94.85 | 13.32 | — |
| Biocon Limited | 148.41 | 1.56 | 0.14% |
| Anthem Biosciences Limited | 78.92 | 15.35 | 0.24% |
| Acutaas Chemicals Ltd | 92.01 | 19.16 | 0.06% |
SAILIFE Stock Price Comparison
Compare SAILIFE with any stock or ETFSAILIFE Holdings
SAILIFE Shareholdings
SAILIFE Promoter Holdings Trend
SAILIFE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
SAILIFE Institutional Holdings Trend
SAILIFE Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
SAILIFE Shareholding Pattern
SAILIFE Shareholding Pattern
SAILIFE Shareholding History
SAILIFE Shareholding History
Mutual Funds Invested in SAILIFE
Mutual Funds Invested in SAILIFE
No mutual funds holding trends are available
Top 5 Mutual Funds holding Sai Life Sciences Limited
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.0238% | Percentage of the fund’s portfolio invested in the stock 1.24% | Change in the portfolio weight of the stock over the last 3 months 0.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 206/273 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.5064% | Percentage of the fund’s portfolio invested in the stock 5.14% | Change in the portfolio weight of the stock over the last 3 months 0.24% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 1/81 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.9734% | Percentage of the fund’s portfolio invested in the stock 5.36% | Change in the portfolio weight of the stock over the last 3 months 0.63% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 5/48 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing SAILIFE stock
smallcases containing SAILIFE stock
Looks like this stock is not in any smallcase yet.
SAILIFE Events
SAILIFE Events
SAILIFE Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
SAILIFE Dividend Trend
No dividend trend available
SAILIFE Dividends
SAILIFE Dividends
SAILIFE Stock News & Opinions
SAILIFE Stock News & Opinions
Sai Life Sciences Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1549.8, up 3.62% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.72% on the day, quoting at 23102.8. The Sensex is at 74677.67, up 0.71%. Sai Life Sciences Ltd has risen around 0.56% in last one month. Meanwhile, Nifty Pharma index of which Sai Life Sciences Ltd is a constituent, has risen around 3.43% in last one month and is currently quoting at 26710.8, up 1.88% on the day. The volume in the stock stood at 7.68 lakh shares today, compared to the daily average of 4.37 lakh shares in last one month.The PE of the stock is 88.15 based on TTM earnings ending June 26.
Sai Life Sciences Limited announced the allotment of 54,500 fully paid-up equity shares with a face value of Rs 1 each under its Employees Stock Option Plan 2008, increasing the company's issued, subscribed, and paid-up equity share capital from Rs 21,24,18,217 to Rs 21,24,72,716. The allotment was approved by the company's board of directors in a meeting held on October 12, 2026, and the exercise price per share was Rs 188.90.
Sai Life Sciences Limited informed the National Stock Exchange of India Limited and the BSE Limited that it has certified the details of securities dematerialized/rematerialized during the quarter ended September 30, 2026, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, and furnished them to all stock exchanges where the company is listed, according to a filing on October 5, 2026. KFin Technologies Limited acted as the Registrar to an Issue and Share Transfer Agent for Sai Life Sciences Limited.
Sai Life Sciences Limited will hold a board meeting on Thursday, November 5, 2026, to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026, as well as other corporate matters. The trading window for the company's securities was closed for designated persons and their immediate relatives from October 1, 2026, and will remain closed until November 7, 2026.
Sai Life Sciences Limited will close its trading window for securities from October 1, 2026, until 48 hours after the announcement of its unaudited financial results for the second quarter and half year ending September 30, 2026, in compliance with SEBI’s Prohibition of Insider Trading Regulations and the company’s Code of Conduct.
Sai Life Sciences Ltd is up for a third straight session today. The stock is quoting at Rs 1617, up 1.03% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.29% on the day, quoting at 23413.6. The Sensex is at 74818.76, up 0.71%. Sai Life Sciences Ltd has gained around 12.61% in last one month. Meanwhile, Nifty Pharma index of which Sai Life Sciences Ltd is a constituent, has gained around 2.67% in last one month and is currently quoting at 26710.1, up 1.25% on the day. The volume in the stock stood at 2.26 lakh shares today, compared to the daily average of 9.32 lakh shares in last one month.The PE of the stock is 94.34 based on TTM earnings ending June 26.
Sai Life Sciences Limited announced the allotment of 24,000 fully paid-up equity shares with a face value of Rs 1 each under its Employees Stock Option Plan 2008, according to a regulatory filing on September 18, 2026. The allotment increased the company's issued, subscribed, and paid-up equity share capital from Rs 21,23,94,217 to Rs 21,24,18,216.
Sai Life Sciences Limited announced the allotment of 14,600 shares under the Employees Stock Option Plan 2008 and 66,000 shares under the Management Employee Stock Option Plan 2018, increasing the company’s issued, subscribed, and paid-up equity share capital from Rs 21,23,13,617 to Rs 21,23,94,216. The exercise price was Rs 188.90 per share for the ESOP 2008 allotment and Rs 23.30 per share for the MESOP 2018 allotment, with a premium of Rs 187.90 and Rs 22.30 respectively.
Sai Life Sciences Ltd rose for a third straight session today. The stock is quoting at Rs 1467.4, up 1.59% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.77% on the day, quoting at 24283.3. The Sensex is at 77581.77, down 0.73%. Sai Life Sciences Ltd has added around 15.35% in last one month. Meanwhile, Nifty Pharma index of which Sai Life Sciences Ltd is a constituent, has added around 3.88% in last one month and is currently quoting at 26750.45, down 0.42% on the day. The volume in the stock stood at 2.73 lakh shares today, compared to the daily average of 5.5 lakh shares in last one month.The PE of the stock is 85.03 based on TTM earnings ending June 26.
Sai Life Sciences Ltd gained for a third straight session today. The stock is quoting at Rs 1383, up 1.21% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.37% on the day, quoting at 24523.85. The Sensex is at 78409.43, down 0.02%. Sai Life Sciences Ltd has risen around 12.2% in last one month. Meanwhile, Nifty Pharma index of which Sai Life Sciences Ltd is a constituent, has risen around 2.37% in last one month and is currently quoting at 26597.5, down 0.44% on the day. The volume in the stock stood at 1.7 lakh shares today, compared to the daily average of 3.72 lakh shares in last one month.The PE of the stock is 83.34 based on TTM earnings ending March 26.
Over the last 5 years, revenue has grown at a yearly rate of 23.28%, vs industry avg of 18.48%
Over the last 5 years, market share increased from 6.73% to 8.08%
Over the last 5 years, net income has grown at a yearly rate of 41.69%, vs industry avg of 12.23%